These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15610789)

  • 1. Cognitive enhancement therapy for schizophrenia.
    Ran MS; Chen EY
    Lancet; 2004 Dec 18-31; 364(9452):2163-5. PubMed ID: 15610789
    [No Abstract]   [Full Text] [Related]  

  • 2. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing treatments for impaired cognition in schizophrenia.
    Minzenberg MJ; Carter CS
    Trends Cogn Sci; 2012 Jan; 16(1):35-42. PubMed ID: 22178120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cognitive deficits in schizophrenia and other psychotic disorders].
    Fagerlund B; Glenthøj BY
    Ugeskr Laeger; 2008 Nov; 170(46):3770-2. PubMed ID: 19014728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive training for divergent thinking in schizophrenia: a pilot study.
    Nemoto T; Yamazawa R; Kobayashi H; Fujita N; Chino B; Fujii C; Kashima H; Rassovsky Y; Green MF; Mizuno M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1533-6. PubMed ID: 19733608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The logical and psychometric prerequisites for cognitive therapy of schizophrenia.
    Spaulding W; Garbin CP; Crinean WJ
    Br J Psychiatry Suppl; 1989 Jul; (5):69-73. PubMed ID: 2605026
    [No Abstract]   [Full Text] [Related]  

  • 7. Aerobic exercise for cognitive deficits in schizophrenia - The impact of frequency, duration, and fidelity with target training intensity.
    Kimhy D; Lauriola V; Bartels MN; Armstrong HF; Vakhrusheva J; Ballon JS; Sloan RP
    Schizophr Res; 2016 Apr; 172(1-3):213-5. PubMed ID: 26852401
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug compliance and cognitive-behavioral therapy in schizophrenia.
    Lecompte D
    Acta Psychiatr Belg; 1995; 95(2):91-100. PubMed ID: 8525853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of neuroleptics on the social behavior disorders of schizophrenic patients].
    Mahé V
    Encephale; 2003 Sep; 29(Pt 2):S28-30. PubMed ID: 14710533
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progress in the development of new generation antipsychotic agents and cognitive behavior therapy for patients with schizophrenia].
    Ikebuchi H
    Seishin Shinkeigaku Zasshi; 2001; 103(12):1022-9. PubMed ID: 11925839
    [No Abstract]   [Full Text] [Related]  

  • 11. [Psychological methods of cognitive deficit reduction. Experiences with a computer training program].
    Olbrich R
    Fortschr Neurol Psychiatr; 1999 Nov; Suppl 2():S74-6. PubMed ID: 10598341
    [No Abstract]   [Full Text] [Related]  

  • 12. Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.
    Carbon M; Correll CU
    CNS Spectr; 2014 Dec; 19 Suppl 1():38-52; quiz 35-7, 53. PubMed ID: 25403863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating impaired cognition in schizophrenia.
    Ibrahim HM; Tamminga CA
    Curr Pharm Biotechnol; 2012 Jun; 13(8):1587-94. PubMed ID: 22283754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for treating cognitive deficits in schizophrenia.
    Bowie CR; Jaga K
    Expert Rev Neurother; 2007 Mar; 7(3):281-7. PubMed ID: 17341176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment resistance and other complicating factors in the management of schizophrenia.
    Strassnig MT; Harvey PD
    CNS Spectr; 2014 Dec; 19 Suppl 1():16-23; quiz 13-5, 24. PubMed ID: 25410772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is memory impairment a rate limiter in cognitive behavioural therapy for chronic schizophrenia?
    Penadés R; Catalán R; Pujol N; Puig O; Guarch J; Masana G; Navarro V; Gastó C
    Psychother Psychosom; 2010; 79(2):129-30. PubMed ID: 20090401
    [No Abstract]   [Full Text] [Related]  

  • 17. Detecting and defusing cognitive traps: metacognitive intervention in schizophrenia.
    Moritz S; Vitzthum F; Randjbar S; Veckenstedt R; Woodward TS
    Curr Opin Psychiatry; 2010 Nov; 23(6):561-9. PubMed ID: 20683332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive-behavioral therapy for medication-resistant schizophrenia: a review.
    Rathod S; Kingdon D; Weiden P; Turkington D
    J Psychiatr Pract; 2008 Jan; 14(1):22-33. PubMed ID: 18212600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive behavior therapy for schizophrenia: a meta-analytical review of randomized controlled trials.
    Sarin F; Wallin L; Widerlöv B
    Nord J Psychiatry; 2011 Jun; 65(3):162-74. PubMed ID: 21563994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: The combined use of atypical antipsychotics and cognitive-behavioural therapy in schizophrenia.
    Shelley AM; Opler LA; Battaglia J; Lucey J
    Can J Psychiatry; 2003 Aug; 48(7):496; author reply 496. PubMed ID: 12971022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.